| NCT06431776 | Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). | NOT_YET_RECRUITING | PHASE3 | 2024-08 | 2027-08 | 2027-01 |
| NCT04544293 | Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-05-19 | 2027-05-30 | 2023-11-30 |
| NCT03597347 | Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection | TERMINATED | PHASE2 | 2019-06-20 | 2020-10-02 | 2020-10-02 |
| NCT03482752 | Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis | TERMINATED | PHASE3 | 2018-04-16 | 2021-01-14 | 2021-01-14 |
| NCT03421743 | Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection | COMPLETED | PHASE2 | 2018-03-01 | 2020-01-13 | 2019-10-15 |
| NCT03181932 | AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis | COMPLETED | PHASE3 | 2017-09-20 | 2021-01-15 | 2020-07-28 |
| NCT02702180 | Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis | COMPLETED | PHASE2 | 2016-03-21 | 2019-09-27 | 2019-04-19 |
| NCT02468908 | Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects | COMPLETED | PHASE1 | 2015-05 | 2015-10 | 2015-10 |
| NCT02104245 | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) | COMPLETED | PHASE3 | 2014-05-28 | 2016-10 | 2016-08-11 |
| NCT01515007 | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) | COMPLETED | PHASE3 | 2014-03-31 | 2016-10 | 2016-08-17 |
| NCT01746095 | Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients | COMPLETED | PHASE2 | 2013-03 | 2014-11 | 2014-11 |
| NCT01537666 | Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics | COMPLETED | PHASE1 | 2011-11 | 2012-03 | 2012-03 |